• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危人群对乙型肝炎筛查和疫苗接种的认识不足。

Lack of awareness of Hepatitis B screening and vaccination in high-risk groups.

机构信息

Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey

出版信息

Turk J Med Sci. 2021 Jun 28;51(3):1229-1233. doi: 10.3906/sag-2008-18.

DOI:10.3906/sag-2008-18
PMID:33433973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8283497/
Abstract

BACKGROUND/AIM: Hepatitis B virus (HBV) vaccination rates are insufficient in high-risk patients worldwide. This study aimed to investigate the screening, immunization, and vaccination rates in three high-risk groups for HBV infection: allogeneic hematopoietic stem cell transplantation (AHSCT), renal transplantation (RT), and chronic hepatitis C (CHC) groups.

MATERIALS AND METHODS

The serological data of consecutive patients between 2014 and 2019 were reviewed using the hospital database.

RESULTS

The HBV screening rates were 100.0%, 90.4%, and 82.4% in the AHSCT, CHC, and RT groups, respectively (p = 0.003). The immunization rates against HBV through either previous exposure or vaccination were 79.5%, 71.7%, and 46.5% in the AHSCT, RT, and CHC groups, respectively (p < 0.001). The HBV vaccination rate was significantly low in the CHC group (71.5%, 69.0%, 34.6% in the AHSCT, RT, and CHC groups, respectively, p < 0.001). If patients lost their immunity due to immunosuppressive therapy were accounted, the vaccination rates increased to 95.2% in the AHSCT group and 72.9% in the RT group. The rate of annual screening for HBV status was 97.9% in the AHSCT group, but it was only 23.9% in the RT group.

CONCLUSION

HBV screening and vaccination rates were significantly lower in the RT and CHC groups than in the AHSCT group.

摘要

背景/目的:乙型肝炎病毒 (HBV) 疫苗接种率在全球高危人群中仍然不足。本研究旨在调查三种乙型肝炎病毒感染高危人群(异基因造血干细胞移植 (AHSCT)、肾移植 (RT) 和慢性丙型肝炎 (CHC) 组)的筛查、免疫和疫苗接种率。

材料和方法

使用医院数据库回顾了 2014 年至 2019 年连续患者的血清学数据。

结果

AHSCT、CHC 和 RT 组的 HBV 筛查率分别为 100.0%、90.4%和 82.4%(p = 0.003)。通过既往暴露或接种疫苗获得的 HBV 免疫率分别为 AHSCT、RT 和 CHC 组的 79.5%、71.7%和 46.5%(p < 0.001)。CHC 组的 HBV 疫苗接种率明显较低(AHSCT、RT 和 CHC 组分别为 71.5%、69.0%和 34.6%,p < 0.001)。如果考虑因免疫抑制治疗而丧失免疫力的患者,AHSCT 组的疫苗接种率增加到 95.2%,RT 组增加到 72.9%。AHSCT 组每年筛查 HBV 状态的比例为 97.9%,而 RT 组仅为 23.9%。

结论

与 AHSCT 组相比,RT 和 CHC 组的 HBV 筛查和疫苗接种率明显较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f0/8283497/5c567ea836fa/turkjmedsci-51-1229-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f0/8283497/5c567ea836fa/turkjmedsci-51-1229-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3f0/8283497/5c567ea836fa/turkjmedsci-51-1229-fig001.jpg

相似文献

1
Lack of awareness of Hepatitis B screening and vaccination in high-risk groups.高危人群对乙型肝炎筛查和疫苗接种的认识不足。
Turk J Med Sci. 2021 Jun 28;51(3):1229-1233. doi: 10.3906/sag-2008-18.
2
Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.喀麦隆雅温得一组医护人员的乙肝感染知晓情况、疫苗认知与接种情况以及血清学特征
BMC Public Health. 2016 Aug 3;15:706. doi: 10.1186/s12889-016-3388-z.
3
Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.印度三级护理医院医护人员的认知水平、疫苗接种覆盖率及加强针需求较低。
J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5. doi: 10.1111/j.1440-1746.2008.05483.x. Epub 2008 Aug 28.
4
Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.自身免疫性肝病患者甲型肝炎病毒和乙型肝炎病毒感染的发病率及疫苗接种率
Am J Gastroenterol. 2008 Jan;103(1):138-46. doi: 10.1111/j.1572-0241.2007.01609.x. Epub 2007 Oct 26.
5
A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.慢性肾脏病3期患者肌肉注射20毫克与40毫克乙肝疫苗后血清转化的随机对照试验
J Med Assoc Thai. 2017 Feb;100 Suppl 1:S1-7.
6
Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.西班牙接受肝移植评估的肝硬化患者中乙型和甲型肝炎病毒标志物的流行情况及疫苗接种指征
Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.
7
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.乙肝疫苗加强针不能为青少年提供额外保护:一项基于学校的横断面研究。
BMC Public Health. 2014 Sep 23;14:991. doi: 10.1186/1471-2458-14-991.
8
World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.2017 年布基纳法索世界肝炎日:乙肝病毒血清流行率和疫苗接种率以实现 2030 年消除目标。
Virol J. 2018 Aug 6;15(1):121. doi: 10.1186/s12985-018-1032-5.
9
Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.加拿大努纳武特地区实施二十年婴儿乙型肝炎病毒(HBV)普遍接种后的血清学和分子流行病学结果。
Vaccine. 2017 Aug 16;35(35 Pt B):4515-4522. doi: 10.1016/j.vaccine.2017.07.040. Epub 2017 Jul 21.
10
High level of exposure to hepatitis B virus infection in a vulnerable population of a low endemic area: A challenge for vaccination coverage.高暴露水平乙型肝炎病毒感染在低流行地区的脆弱人群中:对疫苗接种覆盖率的挑战。
Int J Infect Dis. 2020 Jan;90:46-52. doi: 10.1016/j.ijid.2019.09.029. Epub 2019 Oct 4.

本文引用的文献

1
Regional Epidemiology, Burden, and Management of Hepatitis B Virus in the Middle East.中东地区乙型肝炎病毒的流行病学、负担及管理
Clin Liver Dis (Hoboken). 2020 Jan 29;14(6):212-214. doi: 10.1002/cld.887. eCollection 2019 Dec.
2
The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.意大利 HCV 患者的 HBV 感染负担和 DAA 治疗下再激活的风险。
Dig Liver Dis. 2019 Mar;51(3):434-437. doi: 10.1016/j.dld.2018.09.010. Epub 2018 Sep 21.
3
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.
美国乙型肝炎病毒感染预防:免疫实践咨询委员会的建议。
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.
4
Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.婴儿期全程接种乙肝疫苗的埃及儿童对 HBV 加强剂量的早期和长期记忆应答。
Vaccine. 2018 Apr 5;36(15):2005-2011. doi: 10.1016/j.vaccine.2018.02.103. Epub 2018 Mar 9.
5
Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.2015年美国成年人群疫苗接种覆盖率监测
MMWR Surveill Summ. 2017 May 5;66(11):1-28. doi: 10.15585/mmwr.ss6611a1.
6
Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.加拿大器官捐献者和接受者的乙肝和丙肝血清学特征:单中心10年回顾性研究
Transpl Infect Dis. 2016 Aug;18(4):520-8. doi: 10.1111/tid.12558. Epub 2016 Jul 29.
7
Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study.土耳其乙型和丙型肝炎病毒感染的血清流行率及危险因素:一项实地研究 TURHEP。
Clin Microbiol Infect. 2015 Nov;21(11):1020-6. doi: 10.1016/j.cmi.2015.06.028. Epub 2015 Jul 8.
8
Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study.免费现场疫苗接种和/或医护人员培训对高危人群乙肝疫苗接种可接受性的影响:一项前后群组随机对照研究。
Clin Microbiol Infect. 2014 Oct;20(10):1033-9. doi: 10.1111/1469-0691.12689. Epub 2014 Jul 25.
9
HBV-related events after allogeneic hematopoetic stem cell transplantatıon in a center from Turkey.土耳其某中心异基因造血干细胞移植后与 HBV 相关的事件。
Ann Hematol. 2013 Mar;92(3):395-402. doi: 10.1007/s00277-012-1620-1. Epub 2012 Nov 11.
10
Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions.美国慢性丙型肝炎病毒感染患者中的乙型肝炎病毒感染:流行率、种族/民族差异和病毒相互作用。
Hepatology. 2010 Mar;51(3):759-66. doi: 10.1002/hep.23461.